Biolife Solutions (BLFS) Non-Current Debt (2010 - 2026)
Biolife Solutions' (BLFS) quarterly Non-Current Debt came in at $2.5 million in Q1 2026, down 80.7% year-on-year from $12.9 million in Q1 2025, and down 49.99% on a QoQ basis from $5.0 million in Q4 2025.
Biolife Solutions (BLFS) Non-Current Debt (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 13 years of Non-Current Debt data on file, last reported at $2.5 million in Q1 2026.
- On a quarterly basis, Non-Current Debt fell 80.7% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 80.7% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, down 68.65% from the prior year.
- Non-Current Debt for Q1 2026 stood at $2.5 million, down from $5.0 million in the prior quarter.
- Over the last five years, Non-Current Debt for BLFS reached as high as $26.3 million in Q3 2022 and fell as low as $2.5 million in Q1 2026.
- Historically, Non-Current Debt has averaged $16.9 million across 5 years, with a median of $20.1 million in 2024.
- Across the five-year window, Non-Current Debt jumped 589.19% in 2022 and slumped 80.7% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $25.6 million in 2022, then sank by 31.42% to $17.6 million in 2023, then slipped by 9.23% to $15.9 million in 2024, then plunged by 68.65% to $5.0 million in 2025, then plunged by 49.99% to $2.5 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $2.5 million in Q1 2026, $5.0 million in Q4 2025, and $12.9 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 4.16 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 14.71 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 12.50 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 404.17 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.86 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.58 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 12.95 Mn |
| Dec 31, 2024 | 15.94 Mn |
| Sep 30, 2024 | 20.05 Mn |
| Jun 30, 2024 | 21.07 Mn |
| Mar 31, 2024 | 24.30 Mn |
| Dec 31, 2023 | 17.56 Mn |
| Sep 30, 2023 | 20.94 Mn |
| Jun 30, 2023 | 25.51 Mn |
| Mar 31, 2023 | 23.69 Mn |
| Dec 31, 2022 | 25.61 Mn |
| Sep 30, 2022 | 26.27 Mn |
| Jun 30, 2022 | 6.19 Mn |
| Mar 31, 2022 | 6.31 Mn |
| Dec 31, 2021 | 6.35 Mn |
| Sep 30, 2021 | 6.12 Mn |
| Jun 30, 2021 | 5.02 Mn |
| Mar 31, 2021 | 916,000.00 |
| Dec 31, 2020 | 655,000.00 |